ECONOMY

Coronavirus India Cases: Fresh Cases Drop Below 3 Lakh; Risk Of Adverse Events From Covishield

India reported less than 3 lakh new Covid-19 infections for the first time in almost a month, in a small relief to a healthcare system struggling with a shortage of critical infrastructure and vaccines.

More than 2.81 lakh people tested positive for the coronavirus in the last 24 hours, the lowest since April 20, according to the Health Ministry’s update as of 8 a.m. on May 16.

Recoveries during the same period was significantly higher at nearly 3.79 lakh, taking active cases below 36 lakh for the first time in 10 days. They still account for more than 14% of the country’s total caseload.

Despite fewer cases of infection, more than 4,000 patients succumbed to the illness in a single day. India’s total death toll from the pandemic now stands at 2.74 lakh.

Key figures:

  • Total confirmed cases: 2,49,65,463
  • Total number of active cases: 35,16,997
  • Total patients cured/discharged/migrated: 2,11,74,076
  • Total deaths: 2,74,390
  • Number of fresh cases in last 24 hours: 2,81,386
  • One-day recoveries: 3,78,741
  • One-day deaths: 4,106
  • Total vaccine shots administered: 18,29,26,460

To be sure, data on Covid-19 cases and related deaths may be severely deficient as several states have inadequate testing, chronic underreporting and have been attributing the casualties to other causes.

Meanwhile, National AEFI Committee found a minuscule but definite risk of thromboembolic events after taking the Covishield vaccine.

Adverse events like bleeding and clotting have occurred within 20 days of receiving the Oxford-AstraZeneca Covid-19 vaccine. However, the reporting rate of such cases is around .61/million doses in India.

The committee found no potential risk of thromboembolic events from Bharat Biotech’s Covaxin.

Most Related Links :
usnewsmail Governmental News Finance News

Source link

Back to top button